IE43478L - 16-ethers of fusidic acid - Google Patents

16-ethers of fusidic acid

Info

Publication number
IE43478L
IE43478L IE761227A IE122776A IE43478L IE 43478 L IE43478 L IE 43478L IE 761227 A IE761227 A IE 761227A IE 122776 A IE122776 A IE 122776A IE 43478 L IE43478 L IE 43478L
Authority
IE
Ireland
Prior art keywords
acid
desacetoxy
alpha
alkyl
fusidinic
Prior art date
Application number
IE761227A
Other versions
IE43478B1 (en
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB26989/75A external-priority patent/GB1523803A/en
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of IE43478L publication Critical patent/IE43478L/en
Publication of IE43478B1 publication Critical patent/IE43478B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

Fusidinic acid derivs. of formula (I) and their pharmaceutically acceptable salts and easily hydrolysable esters are new: (C24 and C25 are joined by a single or double bond, Q1 and Q2 are H HO or O. A=O, S or SO. R1 = opt. branched 1-8C alkyl, 2-6C alkenyl or alkynyl, 3-7C cycloalkyl, aryl, aralkyl, heterocyclyl-alkyl or 5-6 membered heterocycle contg. O.S or N atoms; and all these gps. may be substd.). Prepn. is by reacting the 16 alpha-halo analogue, in which the 21-COOH is esterified, with R1AH then hydrolysing. (I) are useful for treating bacterial infections in humans and animals. They are more stable than fusidinic acid itself and are practically non-toxic. They may be administered in usual oral, parenteral or topical forms for an adult dose of 0.25-5, pref. 0.5-3g/day. A specifically claimed cpd., 16-desacetoxy-16 beta-isopropylthiofusidinic acid, was prepd. from 3-O-acetyl-16-desacetoxy-16 alpha-bromofusidinic acid p-nitrobenzyl ester, by reaction with isopropyl mercaptan, then hydrolysis with NaOH. [FR2315296A1]
IE1227/76A 1975-06-25 1976-06-09 New 16-ethers of fusidic acid derivatives IE43478B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB26989/75A GB1523803A (en) 1975-06-25 1975-06-25 16-ethers of fusidic acid derivatives
GB4622975 1975-11-07

Publications (2)

Publication Number Publication Date
IE43478L true IE43478L (en) 1976-12-25
IE43478B1 IE43478B1 (en) 1981-03-11

Family

ID=26258548

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1227/76A IE43478B1 (en) 1975-06-25 1976-06-09 New 16-ethers of fusidic acid derivatives

Country Status (18)

Country Link
JP (1) JPS523051A (en)
AT (1) AT345979B (en)
AU (1) AU500027B2 (en)
CA (1) CA1064906A (en)
DE (1) DE2628360C2 (en)
DK (1) DK143905C (en)
ES (1) ES449257A1 (en)
FI (1) FI55852C (en)
FR (1) FR2315296A1 (en)
GR (1) GR60362B (en)
IE (1) IE43478B1 (en)
IT (1) IT1062245B (en)
LU (1) LU75239A1 (en)
NL (1) NL7606983A (en)
NZ (1) NZ181107A (en)
PT (1) PT65261A (en)
SE (1) SE7607322L (en)
SU (1) SU799670A3 (en)

Families Citing this family (5)

* Cited by examiner, ā€  Cited by third party
Publication number Priority date Publication date Assignee Title
GB1581335A (en) * 1976-07-05 1980-12-10 Leo Pharm Prod Ltd 16-s-acyl derivatives of fusidic acid
US4548922A (en) * 1983-06-06 1985-10-22 Beth Israel Hospital Drug administration
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
ATE230994T1 (en) * 1989-07-07 2003-02-15 Endorech Inc METHOD OF TREATING ANDROGEN-RELATED DISEASES
SK140494A3 (en) * 1992-05-21 1995-07-11 Endorecherche Inc Inhibitors of testosterone 5-alpha-reductase activity

Also Published As

Publication number Publication date
FI55852B (en) 1979-06-29
JPS6350360B2 (en) 1988-10-07
DE2628360C2 (en) 1986-11-06
AU1525076A (en) 1978-01-05
NZ181107A (en) 1978-11-13
SE7607322L (en) 1976-12-26
IE43478B1 (en) 1981-03-11
FR2315296A1 (en) 1977-01-21
AT345979B (en) 1978-10-10
GR60362B (en) 1978-05-19
DK143905C (en) 1982-04-19
AU500027B2 (en) 1979-05-10
CA1064906A (en) 1979-10-23
DK143905B (en) 1981-10-26
LU75239A1 (en) 1977-03-16
FI55852C (en) 1979-10-10
FI761863A (en) 1976-12-26
IT1062245B (en) 1983-09-20
ES449257A1 (en) 1977-12-16
DE2628360A1 (en) 1977-01-13
ATA438776A (en) 1978-02-15
PT65261B (en) 1977-12-07
JPS523051A (en) 1977-01-11
FR2315296B1 (en) 1980-11-07
SU799670A3 (en) 1981-01-23
DK285776A (en) 1976-12-26
NL7606983A (en) 1976-12-28
PT65261A (en) 1976-07-01

Similar Documents

Publication Publication Date Title
GB1432576A (en) Substituted phenylacetic acids
ES455089A1 (en) Oxime derivatives of 7-aminothiazolylacetamido-cephalosporanic acid processes for preparing them and pharmaceutical compositions incorporating them
GB1322988A (en) Thiaheterocyclyl-acetic acid derivatives
IE43478L (en) 16-ethers of fusidic acid
IE33477B1 (en) Naphthacene derivatives
NO176569C (en) Analogous Process for the Preparation of New, Therapeutically Active, Aromatically-Substituted Alkylamino Alkandiphosphonic Acids
GB1247612A (en) Lincomycin derivatives and the manufacture thereof
GB1273705A (en) A method for producing 3,5-diaryl-4-pyrazole acetic acids
ES435604A1 (en) Indolylacetylamino acid derivatives, process for their preparation, and pharmaceutical compositions
GB1369294A (en) Purine-ribofuranoside-2,5,-cyclophosphates
GB1139993A (en) Novel acrylic acid derivatives and process for the preparation thereof
GB1090812A (en) Improvements in or relating to antimicrobially active penicillins and cephalosporins
ES8101576A1 (en) Antibacterial monic acid C derivatives, processes for their preparation and compositions containing them.
ES372927A1 (en) Cyclohexenyl acetic acid compounds
IE42666L (en) Deoxyclavulanic acid and deoxyisoclavulanic acid andĀ¹derivatives thereof
GB1284423A (en) Cyclohexa-1,4-diene-1-acetic acids
IE46100L (en) Clavulanic acid derivatives
GB1457237A (en) Cephalosporin compounds
GB1454726A (en) Penicillins and cephalosporins
IT1097603B (en) Oxo-cycloalkyl-methyl substd. phenyl-alkanoic acid derivs. - useful as analgesic, antipyretic and antiinflammatory agents
GB1510423A (en) Oxadiazole derivatives and their salts process for their preparation and compositions incorporating them
IE39440L (en) Benzoyl benzoic acid derivatives
GB1368251A (en) Theophylinylmethylethanoic acid ester
ES458726A1 (en) Process for the preparation of 7-(1,4-dihydro-4-oxo-1-pyridyl)acetamido-cephem derivatives
GB1433977A (en) Acyl derivatives